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Yersinia pestis DNA was recently detected in human
remains from 2 ancient plague pandemics in France and
Germany. We have now sequenced Y. pestis glpD gene in
such remains, showing a 93-bp deletion specific for biotype
Orientalis. These data show that only Orientalis type
caused the 3 plague pandemics.
T
hree historical pandemics have been attributed to
plague. The causative agent, Yersinia pestis, was dis-
covered at the beginning of the ongoing third pandemic.
The etiology of the 5th-7th–century first pandemic and the
14th-18th–century second pandemic, however, remained
putative until recently (1). Indeed, results of 16S rRNA
gene-based detection using teeth collected from 64 per-
sons’remains in 7 northern Europe sites remained negative
(2). When using different molecular targets and the dental
pulp as a suitable specimen, we detected Y. pestis–specific
DNA fragments in European skeletons of persons suspect-
ed of having historical plague (3–5). Our results were inde-
pendently confirmed on 6th-century Bavarian teeth (6). Y.
pestis comprises biotypes Antiqua, Medievalis, and
Orientalis, recognized on the basis of the conversion of
nitrate to nitrite and fermentation of glycerol. Afourth bio-
type, Microtus, describes Medievalis isolates lacking ara-
binose fermentation. In 1951, Devignat proposed that each
of the first 3 biotypes determined each plague pandemic
(7). This hypothesis was challenged by our multispacer-
typing detection of an Orientalis-like biotype in 5th- to
14th-century dental pulp specimens (5). A 93-bp deletion
from the Y. pestis glpD gene encoding the glycerol-3-phos-
phate dehydrogenase determines lack of glycerol fermen-
tation of the Orientalis biotype (8,9). Isolates of the other
biotypes lack this deletion (8). Here, we establish role of
Orientalis biotype in the 3 pandemics by sequencing the
glpD gene from additional ancient dental pulp specimens.
The Study
We had historical evidence that 3 mass graves exca-
vated in France were used to bury bubonic plague victims.
In Vienne, 12 skeletons, including 5 children, buried with-
in the ruins of a Roman temple have been dated from the
7th–9th centuries both by a 5th-century coin and 14C dat-
ing. In Martigues, 205 skeletons buried in 5 trenches were
dated from 1720 to 1721 on the basis of coins and detailed
parish bills that listed the victims (Figure). In Marseille,
216 skeletons buried in a huge pit dated from a May 1722
epidemic relapse. We previously confirmed the diagnosis
of plague at this site (3). Eighteen teeth from 5 skeletons in
Vienne, 13 teeth from 5 skeletons in Martigues, and 5 teeth
from 3 skeletons in Marseille were processed for the
search for Y. pestis DNAin the dental pulp. The teeth were
processed according to published criteria for authenticat-
ing molecular data in paleomicrobiology (10): 1) there
should be no positive control; 2) negative controls, as sim-
ilar as possible to the ancient specimens, should test nega-
tive; 3) a new primer sequence targeting a genome region
not previously amplified in the laboratory should be used
(suicide PCR); 4) any amplicon should be sequenced; 5) a
second amplified and sequenced target should confirm any
positive result; and 6) an original sequence that differs
from modern homologs should be obtained to exclude con-
tamination.
Accordingly, DNA samples were submitted for sui-
cide-nested PCR conducted by using 1 negative control
(18th-century teeth from skeletons of persons without
anthropologic and macroscopic evidence of infection) for
every 3 specimens. Two microliters (1 µL for nested PCR)
DNA were amplified in a 50-µL mixture containing 10
pmol of each primer, 200 µmol/L each deoxyribonu-
cleotide triphosphate (Invitrogen, Cergy-Pontoise,
France), 1.5 U Taq polymerase (Invitrogen), and 2.5 µLo f
a 50-mmol/L solution of MgCl2 in 1× Taq buffer. Nested
PCR aimed to encompass the entire glpD gene incorporat-
ed primers: glpD-F1: 5′-GGC TAG CCG CCT CAA CAA
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Figure. Skeletons from a mass grave in Martigues, 1720–1721,
yielded molecular evidence for the Yersinia pestis Orientalis bio-
type. Photograph: S. Tzortzis.AAA CAT-3′ (positions 170080–170103, reference: Y.
pestis strain CO92 genome sequence AJ414159.1)/glpD-
R2: 5′-GGT GCC AGT TTC AGT AAC AC-3′ (positions
170402–170383) for initial PCR and glpD-F3: 5′-CGC
TGT TTC GAA CAT TCA GA-3′ (positions
170230–170249) /glpD-R3: 5′-GGC CAAGGC TTC ACT
TAC CA-3′ (positions 170373–170354) for nested PCR.
PCRs were performed in a T3 thermocycler (Biolabo,
Archamps, France) under the following conditions: an ini-
tial 2 min of denaturation at 95°C was followed by 43
cycles (38 cycles for nested PCR) of denaturation for 30 s
at 94°C, annealing for 30 s at 58°C, and extension for 90 s
at 68°C. The amplification was completed by holding the
reaction mixture for 7 min at 68°C. PCR products purified
by using a MultiScreen PCR plate (Millipore Corp.,
Bedford, MA, USA) were sequenced with a DNAsequenc-
ing kit (Big Dye Terminator Cycle Sequencing V2.0; PE
Biosystem, Courtaboeuf, France) and subjected to elec-
trophoresis with the 3100 Genetic Analyzer (Applied
Biosystems, Foster City, CA, USA). The sequences were
compared in the GenBank database (www.ncbi.nlm.
nih.gov/GenBank) using the multisequence alignment
Clustal within the BISANCE environment.
No amplification was observed in 11 negative con-
trols, but 5 of 36 teeth yielded an amplicon of 191-bp
length in 2 of 4 persons’remains from Vienne, 2 of 5 from
Martigues, and 1 of 3 from Marseille. Amplicons exhibit-
ed 100% sequence similarity with that of the Y. pestis
Orientalis glpD gene (GenBank accession nos. AY312359
for tooth 35–0235, Vienne; DQ073797 for tooth
SQ401521 and DQ073798 for tooth SQ408113,
Martigues; and AY312360 for tooth 25–0225, Marseille)
and were characterized by a 93-bp deletion when com-
pared with the glpD gene sequence of the Y. pestis
Medievalis biotype (GenBank accession no. AE 013994).
Conclusions
In this study, contamination of the ancient specimens
is unlikely because of the extensive precautions we took,
including use of the suicide PCR protocol excluding posi-
tive controls (4). Accordingly, glpD gene had never been
investigated in our laboratory before this study, and nega-
tive controls remained negative. The specificity of the
amplicons was ensured by complete similarity of experi-
mental sequences with that of the Y. pestis Orientalis glpD
gene (8). One site (Marseille, 1722) was previously posi-
tive for Y. pestis after sequencing of 2 different targets
(chromosome-borne rpob and plasmid-borne pla genes) in
other specimens collected in other persons’ remains (3).
These results therefore confirm the detection of Y.
pestis–specific DNA in plague patients’ remains from the
first and second epidemics (3–6). We observed a 93-bp in-
frame deletion within the glpD gene sequences obtained
from ancient dental pulp specimens. This deletion has been
found only in Orientalis biotype isolates in 2 independent
studies comprising a total of 77 and 260 Y. pestis isolates,
respectively, of the 4 biotypes (8,9).
After previous demonstration of Y. pestis Orientalis-
type multiple spacer type sequences in Justinian and
medieval specimens (5), we now have cumulative evi-
dence using 2 different molecular approaches that Y. pestis
closely related to the Orientalis biotype was responsible
for the 3 historical plague pandemics.
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